First, while VEGF is a powerful angiogenic signaling molecule, it is not the only signal for angiogenesis, and it is thought that the tumor cells can upregulate other angiogenic signaling pathways, such as hypoxia-inducible factor-1 alpha (HIF-1α) in the presence of bevacizumab [32]. The gene discussed is HIF1A; the disease is neoplasm.